Awarded
5. USTEKINUMAB 130 MG vial perfusión intravenosa
Original language: Spanish
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- ACCORD HEALTHACARE, SLU, AMGEN, S.A., FRESENIUS KABI ESPAÑA, S.A., JANSSEN CILAG, SA, KERN PHARMA, S.L., LABORATORIO STADA SL, Sandoz Farmaceutica
- Contract value
- €2,908
- Bids received
- 7
- Published
- 9 Oct 2025
- Awarded
- 10 Sept 2025
- Contract start
- 10 Sept 2025
- Contract end
- 23 Sept 2026estimated
- Region
- Tenerife